Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Swiss Group for Clinical Cancer Research
Sponsor:
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research
ClinicalTrials.gov Identifier:
NCT01555281
First received: March 8, 2012
Last updated: November 28, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)